Compile Data Set for Download or QSAR
Report error Found 149 Enz. Inhib. hit(s) with all data for entry = 9391
LigandPNGBDBM463460(2-Phenyl-3-(4-(3-(trifluoromethyl)pyridin-2-yl)pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463461(3-(4-Fluorophenyl)-2-(4-(4-(trifluoromethyl)phenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463458(3-(4-Fluorophenyl)-2-(4-(4-methoxyphenyl)piperidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463459(3-(4-Fluorophenyl)-2-(4-(pyridin-2-yl)piperazin-1-...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463456(2-(4-(4-Chlorophenyl)piperidin-1-yl)-3-(4-fluoroph...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463457(2-(4-(3-Chlorophenyl)piperidin-1-yl)-3-(4-fluoroph...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463454(2-(Azepan-1-yl)-3-phenylquinoxaline-6-carboxylic a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463455(3-Phenyl-2-(piperidin-1-yl)quinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463452(2-Phenyl-3-(4-(5-(trifluoromethyl)pyridin-2-yl)pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463453(2-phenyl-3-(4-(quinolin-2-yl)piperazin-1-yl)quinox...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463450(3-(Isopropylamino)-2-phenylquinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463451(2-Phenyl-3-(4-(pyrimidin-2-yl)piperazin-1-yl)quino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463448(3-Morpholino-2-phenylquinoxaline-6-carboxylic acid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463449(3-(4-Methyl-1,4-diazepan-1-yl)-2-phenylquinoxaline...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463442(3-(4-(4-Methoxyphenyl)piperidin-1-yl)-2-phenylquin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463476(3-(Azepan-1-yl)-2-phenylquinoxaline-6-carboxylic a...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463477(3-(4-(4-Chlorophenyl)piperidin-1-yl)-2-phenylquino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463474(2-Phenyl-3-(piperidin-1-yl)quinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463475(2-Phenyl-3-(4-phenylpiperidin-1-yl)quinoxaline-6-c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463472(3-(4-(4-Methoxyphenyl)piperazin-1-yl)-2-phenylquin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463473(3-(4-(3-Chlorophenyl)piperidin-1-yl)-2-phenylquino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463470(2-Phenyl-3-(4-(4-(trifluoromethyl)phenyl)piperidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463471(3-(4-(4-Chlorophenyl)piperazin-1-yl)-2-phenylquino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463468(2-Phenyl-3-(piperazin-1-yl)quinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463469(2-Phenyl-3-(4-phenylpiperazin-1-yl)quinoxaline-6-c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463466(3-(4-(3-Chlorophenyl)piperazin-1-yl)-2-phenylquino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463467(3-(4-Methylpiperazin-1-yl)-2-phenylquinoxaline-6-c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463464(2-Phenyl-3-(4-(4-(trifluoromethyl)phenyl)piperazin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463465(2-Phenyl-3-(4-(pyridin-2-yl)piperazin-1-yl)quinoxa...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463462(2,3-Bis(4-phenylpiperidin-1-yl)quinoxaline-6-carbo...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463463(2,3-Bis(4-methoxyphenyl)-6-(1H-tetrazol-5-yl)quino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified hPASK from insect cells (0.02 μg) is added to a 50 μL reaction mix containing 40 mM HEPES (pH 7.0), 100 mM KCl, 5 mM MgCl2, 1 mM D...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463480(3-(Isopropyl(methyl)amino)-2-phenylquinoxaline-6-c...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463481(3-(Cyclopropyl(methyl)amino)-2-phenylquinoxaline-6...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463478(3-(4-(N-Methylmethan-3-ylsulfonamido)piperidin-1-y...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463479(3-(3,4-Dihydroquinolin-1(2H)-yl)-2-phenylquinoxali...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463462(2,3-Bis(4-phenylpiperidin-1-yl)quinoxaline-6-carbo...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463463(2,3-Bis(4-methoxyphenyl)-6-(1H-tetrazol-5-yl)quino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463460(2-Phenyl-3-(4-(3-(trifluoromethyl)pyridin-2-yl)pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463461(3-(4-Fluorophenyl)-2-(4-(4-(trifluoromethyl)phenyl...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463456(2-(4-(4-Chlorophenyl)piperidin-1-yl)-3-(4-fluoroph...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463458(3-(4-Fluorophenyl)-2-(4-(4-methoxyphenyl)piperidin...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463452(2-Phenyl-3-(4-(5-(trifluoromethyl)pyridin-2-yl)pip...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463453(2-phenyl-3-(4-(quinolin-2-yl)piperazin-1-yl)quinox...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463450(3-(Isopropylamino)-2-phenylquinoxaline-6-carboxyli...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463451(2-Phenyl-3-(4-(pyrimidin-2-yl)piperazin-1-yl)quino...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463448(3-Morpholino-2-phenylquinoxaline-6-carboxylic acid...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463449(3-(4-Methyl-1,4-diazepan-1-yl)-2-phenylquinoxaline...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463496(2-(4-Fluorophenyl)-3-(3-(methoxymethyl)piperidin-1...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463497(3-(3,3-Dimethylpiperidin-1-yl)-2-(4-fluorophenyl)q...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

LigandPNGBDBM463494(3-(Azepan-1-yl)-2-(4-fluorophenyl)quinoxaline-6-ca...)
Affinity DataIC50: 1.00E+3nMAssay Description:Purified PASK (UniProt # Q96RG2; human recombinant N-terminal GST tagged construct, residues 879-1323) from insect cells (final concentration 5 nM) i...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/3/2021
Entry Details
US Patent

Displayed 1 to 50 (of 149 total ) | Next | Last >>
Jump to: